Appointments
Find a Doctor
Online Payment

Dr. Christopher John

M.B.B.S, M.D.(Radiotherapy)

Visiting Consultant - Radiation Oncology

Cancer Centre, Radiation Oncology

Chennai

Educational Qualifications

  • M.B.B.S : (2006-2012) - Chettinad Hospital And Research Institute, Kelambakkam University - The Tamil Nadu Dr. MGR Medical University
    M.D Radiotherapy: (2013-2016) - Vydehi Institute Of Medical Sciences And Research Centre University - Rajiv Gandhi Institute Of Health Science, Karnataka

Clinical Expertise

  • Neuro-oncology
  • Head And Neck Oncology
  • Techniques – Stereotactic Radiosurgery(SRS), Stereotactic Radiotherapy(SRT)

Experience

Work & Teaching Experience

  • Assistant Professor in the Department of Radiation Oncology, SRIHER (2017 TILL DATE)
  • Senior Resident in the Department of Radiation Oncology, SRIHER (2016)
  • Actively involved in various teaching programs for the Post Graduate students
    • M.D Radiation Oncology
    • B.Sc Radiotherapy Technology (Hons)
    • MS OBG, MS ENT
    • Dental, Nursing & Allied Health Sciences

Invited Lectures

  • Invited Speaker in CME on Testicular Tumors organised by Department of Surgical Oncology at SRIHER October 2019
  • Panellist at The National Conference organised by Department of Pathology SRIHER on Recent updates and Multi-disciplinary approach in Respiratory Onco-pathology August 2019

Workshop Attended

  • Apollo Proton Cancer Conference 2019 - Cyberknife Workshop
  • Prodvance Cyberknife Masterclass 2020

Affiliations And Memberships

  • Association Of Radiation Oncologist Of India (AROI)
  • European Society For Radiotherapy And Oncology (ESTRO)

Research & Publication

  • Prognostic significance of metabolic tumour volume and maximum standard uptake value of fluor-18- fluorodeoxyglucose positron emission tomography with computed tomography in nasopharyngeal carcinoma. John C, Venkatasai J, Kondaveeti SS, Murali A, Periakaruppan G, E V, Meenakshisundaram M, Ambalathandi RC, Masilamani H. Contemp Oncol (Pozn). 2021;25(3):153-159. (PubMed Indexed)
  • Concurrent Taxol-Based Doublet Chemotherapy as an Alternative for Intracavitary Brachytherapy Boost in Locally Advanced Carcinoma Cervix- Retrospective Analysis From a Tertiary Care Center. John C, Venkitaraman B, Masilamani H, Kondaveeti SS. Cureus. 2021 Jul 11;13(7). (PubMed Indexed).
  • The Prognostic Role of Maximum Standardized Uptake Value of 18 F-FlouroDeoxy Glucose Positron Emission Tomography-Computed Tomography in Head and Neck Cancer Patients Undergoing Chemoradiotherapy. Srinivas KS, Arunan M, Venkatachalapathy E, John C, Manickavasagam M, Divyambika CV. J Int Soc Prev Community Dent. 2019 Mar-Apr;9(2):159-165. (PubMed Indexed)
  • Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients. Asian Pac J Cancer Prev. 2018;19(11):3099–3103. Published 2018 Nov 29. doi:10.31557/APJCP.2018.19.11.3099 Kondaveeti SS, C V D, John Christopher, M M, S R. (PubMed Indexed)
  • Hypofractionated Intensity Modulated Radiotherapy with Concurrent Chemotherapy for locally advanced squamous cell carcinoma of Head and Neck – Pilot Study - EJPMR 2018 VOLUME 5, MAY ISSUE 5 Bhaskar Vishwanathan*, Christopher, Swathi Reddy
  • Carcinosarcoma (Spindle cell variant) of larynx – Role of Radiotherapy International Journal of Scientific Study May 2016 Volume 4 Issue 2

Ongoing Research

  • Concurrent Chemo-radiotherapy With Taxol/carboplatin In Locally Advanced Carcinoma Cervix

To seek a quick appointment

Copyrights © 2022 Rela Institute & Medical Centre. All Rights Reserved.